Gregory Y. H. Lip

Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification.

L. Fauchier, D. Babuty, N. Clementy, 2018, International journal of cardiology.

Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation Project

G. Lip, Ye Zhang, Yutao Guo, 2016, Scientific Reports.

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists

G. Lip, S. Olsson, L. Rasmussen, 2009, European heart journal.

The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis—a nationwide cohort study

J. Liao, Shih-Ann Chen, Tzeng-Ji Chen, 2024, BMC medicine.

Stroke Prevention in Atrial Fibrillation.

T. Potpara, Juqian Zhang, Y. Gue, 2021, Trends in cardiovascular medicine.

Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients.

V. Roldán, R. López-Gálvez, José Miguel Rivera-Caravaca, 2024, Revista espanola de cardiologia.